美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Advanced Biomed Inc.

3.78

+0.25007.08%

盤後：3.78-0.0001+0.00%18:38 EDT

成交量：4.67萬

成交額：17.07萬

市值：8,268.75萬

市盈率：- -

高：3.80

開：3.60

低：3.45

收：3.53

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Advanced Biomed Inc.

交易所：

NASDAQ

成立時間：

2014

員工人數：

40

公司地址：

122 East 42nd Street,18th Floor,New York,New York,United States

官網：

http://www.advanbiomed.com

郵編：

10168

電話：

- -

傳真：

- -

簡介：

Advanced Biomed Inc.於2021年7月16日在內華達州註冊成立。他們通過Advanced Biomed Inc.和Advanced Biomed HK Limited運營。Advanced Biomed Taiwan負責公司主要技術和產品的運營和設計開發。自2014年成立以來，他們一直專註於整合多個跨學科技術，並建立了自己的微流體技術平台。利用腫瘤細胞的物理和分子生物學特性，通過半導體技術和生物技術的聯合應用，開發了各種先進的原創研究。Advanced Biotech HK是他們的第一家本地化運營公司，主要負責中國的市場運營和管理、本地化生產、產品註冊，以及未來根據中國相關法規在當地市場銷售他們的產品。

董事

名稱

職位

Yi Lu

董事會主席兼首席執行官

Cheang I Kei

獨立董事

Jing Zhang

獨立董事

Mingyue Cai

獨立董事

Hung To Pau

董事

股東

名稱

職位

Yi Lu

董事會主席兼首席執行官

Mingze Yin

首席財務官

Steven I Fang Cheng

首席技術官

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ADVB/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADVB"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADVB\",,,,,undefined,":{"symbol":"ADVB","market":"US","secType":"STK","nameCN":"Advanced Biomed Inc.","latestPrice":3.78,"timestamp":1741982400000,"preClose":3.53,"halted":0,"volume":46686,"hourTrading":{"tag":"盘后","latestPrice":3.7799,"preClose":3.78,"latestTime":"18:38 EDT","volume":115,"amount":431.25,"timestamp":1741991913940},"delay":0,"changeRate":0.070822,"change":0.25,"floatShares":1875000,"shares":21875000,"lyrEps":0,"pbRate":75.59,"amount":170709.978085,"amplitude":0.09915,"volumeRatio":0.19007542602799568,"dividePrice":0,"prevYearClose":4,"fiveDayClose":3.65,"twentyDayClose":4},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADVB\",,,,,undefined,":{"symbol":"ADVB","floatShares":1875000,"roa":"-36.72%","roe":"-239.77%","lyrEps":0,"volumeRatio":0.19007542602799568,"shares":21875000,"dividePrice":0,"high":3.8,"amplitude":0.09915,"preClose":3.53,"low":3.45,"week52Low":3.06,"pbRate":"75.59","week52High":4.1,"institutionHeld":0,"latestPrice":3.78,"eps":0,"divideRate":0,"volume":46686,"delay":0,"ttmEps":0,"open":3.6,"prevYearClose":4,"prevWeekClose":3.65,"prevMonthClose":4,"prevQuarterClose":4,"fiveDayClose":3.65,"twentyDayClose":4,"sixtyDayClose":4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADVB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADVB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADVB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADVB\",params:#withValueCompare:true,withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADVB","date":"2025-03-14","current":-33.554927,"percent":0.833333,"low":-47.528225,"twenty":-36.006243,"median":-34.695604,"eighty":-33.783062,"high":-33.403787,"avg":-36.50643,"sd":4.589548,"marketCap":76389200},"quantilePoints":[{"date":"2025-03-07","current":-34.695604,"twenty":-44.961701,"median":-41.111914,"eighty":-37.262128,"marketCap":78986000},{"date":"2025-03-14","current":-33.554927,"twenty":-36.006243,"median":-34.695604,"eighty":-33.783062,"marketCap":76389200}],"customCompares":[],"updateTime":1742129815229},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1821058753,"yearFounded":2014,"employeeNum":40,"address":"122 East 42nd Street,18th Floor,New York,New York,United States","zipCode":"10168"},"stockCompanyDetail":{"websiteUrl":"http://www.advanbiomed.com","stockEarnings":[{"period":"1week","weight":0.0356},{"period":"1month","weight":-0.055},{"period":"ytd","weight":-0.055}],"compareEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":-0.0672},{"period":"3month","weight":-0.0685},{"period":"6month","weight":0.0014},{"period":"1year","weight":0.0929},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Advanced Biomed Inc.於2021年7月16日在內華達州註冊成立。他們通過Advanced Biomed Inc.和Advanced Biomed HK Limited運營。Advanced Biomed Taiwan負責公司主要技術和產品的運營和設計開發。自2014年成立以來，他們一直專註於整合多個跨學科技術，並建立了自己的微流體技術平台。利用腫瘤細胞的物理和分子生物學特性，通過半導體技術和生物技術的聯合應用，開發了各種先進的原創研究。Advanced Biotech HK是他們的第一家本地化運營公司，主要負責中國的市場運營和管理、本地化生產、產品註冊，以及未來根據中國相關法規在當地市場銷售他們的產品。","exchange":"NASDAQ","name":"Advanced Biomed Inc.","nameEN":"Advanced Biomed Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ADVB\",market:\"US\",,,undefined,":{"directors":[{"name":"Yi Lu","position":"董事會主席兼首席執行官"},{"name":"Cheang I Kei","position":"獨立董事"},{"name":"Jing Zhang","position":"獨立董事"},{"name":"Mingyue Cai","position":"獨立董事"},{"name":"Hung To Pau","position":"董事"}],"executives":[{"name":"Yi Lu","position":"董事會主席兼首席執行官"},{"name":"Mingze Yin","position":"首席財務官"},{"name":"Steven I Fang Cheng","position":"首席技術官"}]}}}